Safety research
AOD-9604 Side Effects — Research Findings
Side effect profiles documented in published AOD-9604 research depend on dose, route of administration, and model system. The following are commonly reported findings from research literature — not from personal use contexts.
- Minimal adverse events reported in published lipolysis research
- Does not affect IGF-1 or insulin sensitivity in preclinical studies
- Injection site reactions possible with subcutaneous administration
- Generally well-tolerated at research doses in literature



